# US 2025/0367282 A1 · Polycation carrier particle

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0367282 A1
- Document ID: US20250367282A1
- Status: Published application
- Kind: A1
- Application number: 18/871,946
- Filed: 2023-06-08
- Published: 2025-12-04
- Earliest claimed: 2022-06-08
- Assignees: Allarta Life Science Inc.
- Applicants: Allarta Life Science Inc.
- Inventors: Samantha ROS; Mitchell Arbuthnot JOHNSON; Nicole Aliida MANGIACOTTE; Nicholas Alexander Despard BURKE; Harald Donald Helmut STOVER
- Web page: https://patentgrep.com/patent/US20250367282A1

## CPC

- A61K 9/1635: {obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates}
- A61K 39/385: Haptens or antigens, bound to carriers
- C08F 220/20: of polyhydric alcohols or phenols {, e.g. 2-hydroxyethyl (meth)acrylate or glycerol mono-(meth)acrylate}
- C08J 3/12: Powdering or granulating
- C12N 15/88: using microencapsulation, e.g. using {amphiphile} liposome vesicle
- A61K 2039/53: {DNA (RNA) vaccination}
- A61K 2039/64: {characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units}
- C08J 2333/08: Homopolymers or copolymers of acrylic acid esters
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

A polycation carrier particle obtained by the polymerization of a multiacrylate monomer with one or more hydrophilic monomers to form crosslinks. The polycation carrier particle has a net positive electric charge. The multiacrylate monomer and the hydrophilic monomer(s) are as defined herein.

## Claims

### Claim 1

A polycation carrier particle obtained by the polymerization of an acrylate monomer with one or more hydrophilic monomers to form crosslinks, wherein the polycation carrier particle has a net positive electric charge and wherein the acrylate monomer is selected from formula I or formula V
and wherein R and R″ are each independently a hydrogen, a C1-C14 linear or branched alkyl, a C3-C8 cycloalkyl, or a 5 to 10 membered aryl or heteroaryl ring, optionally terminated by a polymerizable group, capable of crosslinking with the one or more hydrophilic monomers,
R′ is a C2-C14 linear or branched alkyl, a C3-C8 cycloalkyl, or a 5 to 10 membered aryl or heteroaryl ring, and R′ is terminated by at least one polymerizable group, capable of crosslinking with the one or more hydrophilic monomers,
the alkyl, cycloalkyl, aryl and heteroaryl can be optionally substituted and optionally interrupted by one or more oxygen, sulfur or nitrogen atoms, and
R2 is C2 or C3 and wherein C3 is linear or cyclic.

### Claim 2 (depends on 1)

The polycation carrier particle of claim 1, wherein the polymerizable group is selected from an acrylate group, a methacrylate group, a (meth)acrylamide group, or a styrene group.

### Claim 3 (depends on 1)

The polycation carrier particle of claim 1, wherein the acrylate monomer of formula I is a multiacrylate monomer of formula II
wherein R1 is hydrogen or a C1-C14 linear, branched or cyclic alkyl that is optionally substituted and optionally interrupted by one or more oxygen, sulfur or nitrogen atoms and optionally terminated with an acrylate group,
R2 is C2 or C3 and wherein C3 is linear or cyclic,
R3 is a C2-C14 linear or branched alkyl, that is optionally substituted and optionally interrupted by one or more oxygen, sulfur or nitrogen atoms.

### Claim 4 (depends on 1, 3)

The polycation carrier particle of claim 3, wherein the multiacrylate monomer is of formula III
wherein R1, and R2 are as defined in claim 1, and R4 is —CH2—CH2—O— or —CH2—CH2—CH2—O— and the terminal CH2 group of R4 is linked to the oxide of the terminal acrylate group, and n is an integer selected from 1, 2, 3, or 4.

### Claim 5 (depends on 1, 3)

The polycation carrier particle of claim 3, wherein the multiacrylate monomer is of formula IV
wherein R1 and R2 are as defined in claim 1, R1′ has the same definition as R1, R2′ is C2-C3 and wherein C3 is linear or cyclic, and m is an integer selected from 0, 1, 2, 3 or 4.

### Claim 6 (depends on 1)

The polycation carrier particle of claim 1, wherein the acrylate monomer of formula V is a multiacrylate monomer of formula VI
wherein R1 and R5 are independently hydrogen or a C1-C14 linear, branched or cyclic alkyl that is optionally substituted and optionally interrupted by one or more oxygen, sulfur or nitrogen atoms and optionally terminated with an acrylate group,
R2 is C2 or C3 and wherein C3 is linear or cyclic,
R3 is a C2-C14 linear or branched alkyl, that is optionally substituted and optionally interrupted by one or more oxygen, sulfur or nitrogen atoms.

### Claim 7 (depends on 6)

The polycation carrier particle of claim 6, wherein the multiacrylate monomer is of formula VII
wherein R1, and R5 are as defined in claim 6, and R4 is —CH2—CH2—O— or —CH2—CH2—CH2—O— and the terminal CH2 group of R4 is linked to the oxide of the terminal acrylate group, and n is an integer selected from 1, 2, 3, or 4.

### Claim 8

(canceled)

### Claim 9 (depends on 5, 6)

The polycation carrier particle of claim 5, wherein the multiacrylate monomer is of formula VIII
wherein R1 and R5 are as defined in claim 6, R2 is C2 or C3 and wherein C3 is linear or cyclic, m is an integer selected from 0, 1, 2, 3, or 4 and R1, R2 and R5′ independently share the definitions of R1, R2 and R5, respectively.

### Claim 10 (depends on 1)

The polycation carrier particle of claim 1, wherein the acrylate monomer is selected from:

### Claim 11 (depends on 1)

The polycation carrier particle of claim 1, wherein the multiacrylate monomer is methyldiethanolamine diacrylate (DXL).

### Claim 12 (depends on 1)

The polycation carrier particle of claim 1, wherein the hydrophilic monomer is of formula IX
wherein R6 is —O—(CH2)p—Y, —NJK or —NJ2K+, p is an integer selected from 2, 3, or 4, Y is defined as OH, COOH, NJ2, NJ3+, or ONJ2 and each J is independently defined as H, methyl or ethyl, and K is ethyl, propyl or butyl that is optionally branched and optionally substituted, and R7 is hydrogen or methyl.

### Claim 13 (depends on 1)

The polycation carrier particle of claim 1, wherein the hydrophilic monomer is of formula X
wherein R8 is a C2-C4 linear alkyl and X is selected from hydroxyl, carboxyl, tertiary amine, quaternary ammonium or amide, and the amine is optionally substituted by methyl or ethyl groups.

### Claim 14

(canceled)

### Claim 15 (depends on 1)

The polycation carrier particle of claim 1, wherein the polycation carrier particle has a size of from 200 nm to 5 μm.

### Claim 16 (depends on 1)

The polycation carrier particle of claim 1, wherein a molar percent ratio of the acrylate monomer to the one or more hydrophilic monomers is from 15/85 to 50/50.

### Claim 17 (depends on 1)

The polycation carrier particle of claim 1, further comprising a cargo material complexed with the polycation carrier particle.

### Claim 18

(canceled)

### Claim 19 (depends on 1)

A method of producing a polycation carrier particle as defined in claim 1, the method comprising:
providing an acrylate monomer as defined in claim 1 and one or more hydrophilic monomers as defined in of claim 1, and,
crosslinking the acrylate monomer with the one or more hydrophilic monomers.

### Claim 20 (depends on 19)

The method of claim 19, wherein the step of crosslinking comprises performing one of a precipitation polymerization, a micro emulsion polymerization, a dispersion polymerization, an inverse-suspension polymerization or an inverse emulsion polymerization.

### Claim 21 (depends on 19)

The method of claim 19, wherein only one hydrophilic monomer is provided and the acrylate monomer to the hydrophilic monomer molar percent ratio is 30±15/70±15.

### Claim 22 (depends on 19)

The method of claim 19, wherein two hydrophilic monomers are provided and the acrylate monomer to the two hydrophilic monomers molar percent ratio is 33±10/33±10/33±10.

### Claim at position 23

23-27. (canceled)

### Claim 28 (depends on 1)

A method of inducing an immune response in vivo comprising administering to a subject in need thereof the polycation carrier particle of claim 1 complexed with an antigen or a nucleic acid encoding an antigen or encapsulating a vaccine composition.

### Claim at position 25

29-32. (canceled)
